Overview

Gilead Sciences, Inc. is a biopharmaceutical company that is focused on advancing medicines to prevent and treat diseases, including human immunodeficiency virus (HIV), viral hepatitis...

Open

$169.51

Prior close

$170.68

Today's high

$172.50

Today's low

$166.51

52 Week high

$175.65

52 Week low

$116.88

News

Business Wire • 3 days ago • GILD

Gilead Sciences to Present at Upcoming Fourth Quarter 2026 Investor Conferences

Seeking Alpha • 3 days ago • GILD

Gilead: Q3 Earnings Overview - It's Time To Consider Selling After Stellar Year

Zacks Investment Research • 3 days ago • GILD

GILD Beats Q3 Earnings on HIV Strength & Trodelvy Sales Growth

Zacks Investment Research • 3 days ago • GILD

GILD Q3 Earnings Call Highlights Raised Outlook and Pricing Risks

Seeking Alpha • 3 days ago • GILD

Gilead: The Business Is Growing, But The Valuation No Longer Works